Article
Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.
Oncology reports - 1 May 2012
Fang Wei-Jia, Mou Hai-Bo, Jin Da-Zhi, Zheng Yu-Long, Zhao Peng, Mao Chen-Yu, Peng Ling, Huang Ming-Zhu, Xu Nong
Abstract excerpt
S-1 is an oral antitumor agent that contains tegafur, which is converted to fluorouracil (5-FU) in the human body. Cytochrome P450 2A6 (CYP2A6) is the principal enzyme responsible for bioconversion of tegafur to 5-FU. A number of CYP2A6 polymorphisms have been associated with variations in enzyme...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
